Poly Medicure (POLYMED) Share Price Falls 5.35% Today; Mid Cap Slides to Rs 1,468

Poly Medicure Share Price is trading at Rs 1,468, down 5.35% today, with market capitalisation at Rs 15,721.16 crore. The move places Poly Medicure in the Mid Cap category and brings the Poly Medicure Share Price back into focus for investors tracking healthcare names. The price move is confirmed in Univest data; a company-specific reason has not been established. The stock opened at Rs 1,557.05, touched the same intraday high, and later moved to a low of Rs 1,467.30. For readers following Poly Medicure Share Price Today and Poly Medicure Stock News, the session is notable because the fall occurred without a verified news trigger in the available record, making price action, valuation and peer context the main lenses for analysis.

Poly Medicure Share Price Today matters because the stock is being watched not just for the decline, but also for how its valuation compares with the healthcare peer set. The latest Univest figures show a richer P/E than the sector median and a P/B above the sector median, while ROE and ROCE sit close to the middle of the same-industry range. That combination makes the Poly Medicure Share Price useful for investors looking at both market reaction and fundamental context.

Poly Medicure (POLYMED) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,468
Previous Close	Rs 1,551
Today's Move	-Rs 83.00 (-5.35%)
Open	Rs 1,557.05
High	Rs 1,557.05
Low	Rs 1,467.3
Market Capitalisation	Rs 15,721.16 crore
Market Cap Category	Mid Cap

Poly Medicure Share Price Today shows a clear intraday decline from Rs 1,551, the previous close, to Rs 1,468, a fall of Rs 83. The stock opened at Rs 1,557.05, matched that as its day high, and touched a low of Rs 1,467.30. The day range therefore stayed tight at the top and then shifted lower through the morning. With a market capitalisation of Rs 15,721.16 crore, Poly Medicure remains a Mid Cap company, so the Poly Medicure Share Price is being assessed in a size bucket that often attracts both growth and valuation scrutiny. For today’s trade, the important fact is the direction and scale of the fall, not a separate trend narrative. The Poly Medicure Share Price is lower, the price move is verified, and the market is still pricing the stock in real time as of 21 October 2026 at 12:22:53 PM IST. That sets up the fundamental read-through that follows.

Poly Medicure (POLYMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 15,721.16 crore
P/E Ratio	49.9x
P/B Ratio	4.94x
ROE	10.94%
ROCE	14.05%
EPS	Rs 31.09
Book Value Per Share	Rs 313.97
Dividend Yield	0.23%

Poly Medicure (POLYMED) fundamental metrics show P/E 49.9x, P/B 4.94x, ROE 10.94%, ROCE 14.05%. These ratios show where the company stands today and are not a call to buy or sell.

Poly Medicure has a market capitalisation of Rs 15,721.16 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.9x, P/B at 4.94x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.94% and ROCE of 14.05%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 31.09, book value per share of Rs 313.97, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.48x, median ROE of 12.34%, median ROCE of 13.82%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	49.9x
Benchmark Median P/E	32.48x
Benchmark Average P/E	84.01x
Benchmark P/E Range	8.46x to 910.91x
Company P/B Ratio	4.94x
Benchmark Median P/B	3.16x
Benchmark Average P/B	3.66x
Company ROE	10.94%
Benchmark Median ROE	12.34%
Benchmark Average ROE	15.27%
Company ROCE	14.05%
Benchmark Median ROCE	13.82%
Benchmark Average ROCE	16.7%
Company Market Capitalisation	Rs 15,721.16 crore
Benchmark Median Market Cap	Rs 173.25 crore
Benchmark Average Market Cap	Rs 6,086.71 crore

Poly Medicure (POLYMED) operates in the Healthcare sector, within the Medical Equipment/Supplies/Accessories industry.

Poly Medicure (POLYMED) has a P/E ratio of 49.9x, which is above the benchmark median of 32.48x, a difference of +53.63%. A P/E difference of this kind is a reference point rather than a recommendation.

Poly Medicure (POLYMED) has a ROE of 10.94%, which is below the benchmark median of 12.34%, a difference of -11.35%. Poly Medicure (POLYMED) has a ROCE of 14.05%, which is above the benchmark median of 13.82%, a difference of +1.66%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
LENSKART SOLUTIONS	LENSKART	1,11,141.66	169.59	12.43	6.85	12.55
Q-LINE BIOTECH	QLINE	1,400.97	25.14	2.87	25.55	22.23
3B Blackbio Dx	3BBLACKBIO	1,141.5	20.56	3.42	20.22	25.9
LAXMI DENTAL	LAXMIDENTL	1,003.19	32.48	4.09	11.95	13.29
Hemant Surgical Industries	HSIL	899.3	49.44	6.25	12.73	13.58

Poly Medicure (POLYMED) has a P/E ratio of 49.9x compared with the displayed peer median of 32.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.94% compares with a peer median of 12.73% across the companies shown in the table. ROCE stood at 14.05% versus the displayed peer median of 13.58%, providing a capital-efficiency comparison. Poly Medicure (POLYMED) has a market capitalisation of Rs 15,721.16 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Poly Medicure

• Poly Medicure Share Price is down 5.35% in today’s trade, with the decline confirmed as a live price event on Univest.
• The stock’s P/E of 49.9 and P/B of 4.94 keep Poly Medicure Share Price in a richer valuation bracket than the industry median.
• ROE of 10.94% and ROCE of 14.05% give investors a clear profitability and capital-return reference point.
• Poly Medicure Share Price is being assessed alongside same-industry peers where several names trade at lower multiples.
• The company’s Rs 15,721.16 crore market capitalisation places it well above the benchmark average and many listed peers.

About Poly Medicure

Poly Medicure operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The company is part of the mid-sized listed universe in terms of category, but its market capitalisation is materially above the same-industry average. Poly Medicure Share Price is therefore read alongside its business profile as a healthcare equipment name rather than only as a price chart event. The company description in the current record points to its place within medical equipment and supplies, and that industry position is what frames its valuation, peer set and market relevance. For readers tracking Poly Medicure Stock News, the business context matters as much as the day’s decline.

Track Poly Medicure Share Price on Univest

Use Poly Medicure (POLYMED) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Investors can track Poly Medicure Share Price on Univest for live updates, valuation ratios, 52-week levels and market insights in one place. The platform also helps users follow Poly Medicure Share Price Today alongside Poly Medicure Fundamental Analysis, peer comparison and sector context. For regular monitoring, Univest keeps the stock view tied to price action, financial ratios and company-level facts.

Frequently Asked Questions

Why is Poly Medicure Share Price falling today?

Ans. Poly Medicure Share Price is lower by 5.35% today and is trading at Rs 1,468. According to Univest data, the price event is confirmed, but no company-specific catalyst is established in the available record.

What is Poly Medicure Share Price today?

Ans. Poly Medicure Share Price is trading at Rs 1,468, down Rs 83 from the previous close of Rs 1,551. The stock opened at Rs 1,557.05 and touched a low of Rs 1,467.30 during the current trade.

What is the market capitalisation of Poly Medicure ?

Ans. Poly Medicure has a market capitalisation of Rs 15,721.16 crore. In the same industry benchmark, that is above the average market cap and well above the median, which matters for Poly Medicure Share Price analysis.

How does Poly Medicure Share Price compare with sector valuation?

Ans. Poly Medicure Share Price trades at a P/E of 49.9 and a P/B of 4.94. Both are above the same-industry median, so the stock sits in a richer valuation zone than the benchmark middle.

What do ROE and ROCE show for Poly Medicure Share Price?

Ans. ROE is 10.94% and ROCE is 14.05% for Poly Medicure Share Price. ROCE is slightly above the sector median, while ROE is below the median, giving investors a mixed but factual profitability picture.

What does Poly Medicure EPS mean for investors?

Ans. Poly Medicure has an EPS of Rs 31.09, which shows earnings attributable to each share. For Poly Medicure Share Price, EPS helps investors judge whether the current valuation is backed by per-share earnings power.

What is the book value for Poly Medicure Share Price?

Ans. Book value stands at Rs 313.97 per share. For Poly Medicure Share Price, this is the accounting net worth behind each share and is useful when comparing the stock’s P/B ratio with peers and the sector.

Does Poly Medicure pay a dividend?

Ans. Poly Medicure has a dividend yield of 0.23%. That means the current payout reference is modest, so dividend yield is a small part of the Poly Medicure Share Price story compared with valuation and earnings metrics.

How does Poly Medicure compare with healthcare peers?

Ans. In peer comparison, Poly Medicure Share Price sits above several listed peers on valuation, while its market capitalisation is much larger than the smaller companies in the group. That scale difference is important in relative analysis.